Skip to content
Preprint · CC-BY via OpenAlex

Inhibition of S6K lowers age-related inflammation and immunosenescence and increases lifespan through the endolysosomal system

Pingze Zhang, James H. Catterson, Sebastian Grönke, Linda Partridge

bioRxiv (Cold Spring Harbor Laboratory) · 2022 · ▲ 2 citations

Abstract

Abstract The nutrient-sensing Target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition) complex 1 (TORC1) is an evolutionarily conserved regulator of longevity and healthspan(definition). S6 kinase (S6K) is an essential downstream mediator for the effect of TORC1 on longevity. However, mechanistic insights on how TORC1-S6K signalling promotes lifespan and healthspan are still limited. Here we show that activity of S6K in the Drosophila fat body is essential for rapamycin-mediated longevity. Fat-body-specific activation of S6K blocked lifespan extension upon rapamycin feeding and induced accumulation of multilamellar lysosomal enlargements. By proteomics analysis we identified Syntaxin 13 (Syx13) as an important downstream mediator of TORC1-S6K signalling involved in regulating lysosomal morphology. Inhibition of TORC1-S6K signalling decreased age-associated hyperactivation of the NF-κB-like IMD pathway in the fat body and promoted bacterial clearance, mediated by Syx13, suggesting that lysosomal and immune function are connected during ageing. Middle-age-onset repression of IMD pathway in the fat body by Relish RNAi promoted bacteria clearance and extended fly lifespan. In mice, chronic rapamycin treatment elevated Syntaxin 12/13 (Stx12) level in liver. We identified alleviated immune processes in the aged liver as a common signature of S6K1-deficient and rapamycin-treated mice. Thus, our results indicate that suppression of the TORC1-S6K-Syx13 axis ameliorates both inflammageing and immunosenescence in hepatic tissues via the endolysosomal system and thereby extends longevity, providing a mechanistic explanation for the effects of rapamycin and suppression of S6K on immune function and lifespan in model organisms and, potentially, humans.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1101/2022.08.25.505264
Canonical
link ↗
Fetched
2026-10-07 MST

Cite this

APA
Zhang, P., Catterson, J.H., Grönke, S., &amp; Partridge, L. (2022). Inhibition of S6K lowers age-related inflammation and immunosenescence and increases lifespan through the endolysosomal system. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/2022.08.25.505264
Vancouver
Zhang P, Catterson JH, Grönke S, Partridge L. Inhibition of S6K lowers age-related inflammation and immunosenescence and increases lifespan through the endolysosomal system. bioRxiv (Cold Spring Harbor Laboratory). 2022. doi:10.1101/2022.08.25.505264.
BibTeX
@unpublished{pingze2022Inhibi, title = {Inhibition of S6K lowers age-related inflammation and immunosenescence and increases lifespan through the endolysosomal system}, author = {Pingze Zhang and James H. Catterson and Sebastian Grönke and Linda Partridge}, journal = {bioRxiv (Cold Spring Harbor Laboratory)}, year = {2022}, doi = {10.1101/2022.08.25.505264}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings